Arava stands as a cornerstone in the management of rheumatoid arthritis, offering targeted relief and improved quality of life for individuals grappling with this chronic autoimmune condition. Manufactured by Sanofi-Aventis Pasteur India Pvt. Ltd., each tablet of Arava contains 20 mg of Leflunomide, a potent disease-modifying antirheumatic drug (DMARD) known for its efficacy in controlling inflammation and slowing disease progression.

Key Features:

1. Rheumatoid Arthritis Management: Arava is indicated for the treatment of rheumatoid arthritis, a debilitating autoimmune disorder characterized by joint inflammation, pain, and progressive joint damage. Leflunomide, the active ingredient in Arava, exerts its therapeutic effects by suppressing immune activity and reducing inflammation, ultimately alleviating symptoms and preserving joint function.
2. Disease-Modifying Action: Arava belongs to the class of DMARDs, which are pivotal in the long-term management of rheumatoid arthritis. Unlike symptomatic treatments that merely alleviate pain and inflammation, Leflunomide targets the underlying disease process, slowing the progression of joint damage and preventing irreversible disability, thereby improving overall outcomes and prognosis for patients.
3. Potent Strength: Each tablet of Arava contains 20 mg of Leflunomide, ensuring a potent and effective dosage for combating rheumatoid arthritis. This standardized strength allows for consistent therapeutic outcomes, facilitating optimal disease control and symptom management over the course of treatment.
4. Tablet Formulation: Arava is available in tablet form, offering convenient oral administration. The tablets are designed for ease of use, enabling patients to adhere to their treatment regimen without hassle. Each pack of Arava contains 30 tablets, providing a month’s supply for continuous therapy.
5. Clinically Proven Efficacy: The efficacy and safety of Arava in rheumatoid arthritis management are supported by robust clinical evidence and real-world experience. Clinical trials have demonstrated Leflunomide’s ability to reduce disease activity, improve physical function, and enhance quality of life in patients with rheumatoid arthritis, establishing it as a trusted and proven treatment option.
6. Prescription Requirement: Arava is a prescription medication, emphasizing the importance of medical supervision and individualized treatment plans. Patients should consult with their healthcare providers to determine the most appropriate dosage, monitor treatment response, and address any concerns or questions regarding therapy.

Choose Arava with Leflunomide for a treatment journey that prioritizes rheumatoid arthritis control, joint health, and overall well-being. Trust in the power of Arava to be your ally in the fight against rheumatoid arthritis, offering targeted relief, improved mobility, and a pathway to a brighter, more active life.